Functional neurologic disorders

CONTINUUM Lifelong Learning in Neurology

Volumn 21, Issue 3, 2015, Pages 818-837

  Stone, Jon ^a   Carson, Alan ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ANAMNESIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; CONVERSION DISORDER; DISEASE CLASSIFICATION; DISSOCIATIVE DISORDER; DSM-5; EVIDENCE BASED PRACTICE; FACTITIOUS DISEASE; FUNCTIONAL DISEASE; FUNCTIONAL NEUROLOGIC DISORDER; HUMAN; HYPNOSIS; ICD-11; MALINGERING; MEDICAL TERMINOLOGY; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROLOGIST; NEUROSCIENCE; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PSYCHOTHERAPY; REHABILITATION CARE; REVIEW; SEDATION; TRANSCRANIAL MAGNETIC STIMULATION; ADOLESCENT; ADULT; CASE REPORT; COMPLICATION; FEMALE; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; PSYCHOLOGICAL RATING SCALE;

ADOLESCENT; ADULT; FEMALE; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; PHYSICAL THERAPY MODALITIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY;

EID: 84930461780     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000466669.02477.45     Document Type: Review

References (57)

1. Fahn S, Olanow CW. "Psychogenic movement disorders": they are what they are. Mov Disord 2014;29(7):853-856.
2. Edwards MJ, Stone J, Lang AE. From psychogenic movement disorder to functional movement disorder: it's time to change the name. Mov Disord 2014;29(7):849-852. doi:10.1002/mds.25562.
3. Stone J, Carson A, Duncan R, et al. Who is referred to neurology clinics?Vthe diagnoses made in 3781 new patients. Clin Neurol Neurosurg 2010;112(9):747-751. doi:10.1016/j.clineuro.2010.05.011.
4. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999;354(9182):936-939.
5. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 2001;51(1):361-367.
6. Carson A, Stone J, Hibberd C, et al. Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry 2011;82(7):810-813. doi:10.1136/jnnp.2010.220640.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association, 2013.
8. WorldHealth Organization. ICD-11 beta draft: joint linearization for mortality andmorbidity statistics. apps.who.int/classifications/icd11/browse/l-m/en. Updated February 19, 2015. Accessed April 6, 2015.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV.Washington, DC: American Psychiatric Association, 2000.
10. Centers for Disease Control and Prevention, International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). www.cdc.gov/nchs/icd/icd10cm.htm. Updated September 26, 2014. Accessed April 6, 2015.
11. Stone J, LaFrance WC, Brown R, et al. Conversion disorder: current problems and potential solutions for DSM-5. J Psychosom Res 2011;71(6):369-376. doi:10.1016/j.jpsychores.2011.07.005.
12. Stone J, Hallett M, Carson A, Bergen D, Shakir R. Functional disorders in the neurology section of ICD-11: a landmark opportunity. Neurology 2014;83(24):2299-2301.
13. Stone J, Warlow C, Sharpe M. Functional weakness: clues to mechanism from the nature of onset. J Neurol Neurosurg Psychiatry 2012;83(1):67-69. doi:10.1136/jnnp-2011-300125.
14. Pareé s I, Kojovic M, Pires C, et al. Physical precipitating factors in functional movement disorders. J Neurol Sci 2014;338(1-2):174-177. doi:10.1016/j.jns.2013.12.046.
15. Hendrickson R, Popescu A, Dixit R, et al. Panic attack symptoms differentiate patients with epilepsy from those with psychogenic nonepileptic spells (PNES). Epilepsy Behav 2014;37:210-214. doi:10.1016/j.yebeh.2014.06.026.
16. Stone J. Functional neurological disorders: the neurological assessment as treatment. Neurophysiol Clin 2014;44(4):363-373. doi:10.1016/j.neucli.2014.01.002.
17. Stone J, Carson AJ. The unbearable lightheadedness of seizing: wilful submission to dissociative (non-epileptic) seizures. J Neurol Neurosurg Psychiatry 2013;84(7):822-824. doi:10.1136/jnnp-2012-304842.
18. Daum C, Hubschmid M, Aybek S. The value of 'positive' clinical signs for weakness, sensory and gait disorders in conversion disorder: a systematic and narrative review. J Neurol Neurosurg Psychiatry 2014; 85(2):180-190. doi:10.1136/jnnp-2012-304607.
19. Zeuner KE, Shoge RO, Goldstein SR, et al. Accelerometry to distinguish psychogenic from essential or parkinsonian tremor. Neurology 2003;61(4):548-550. doi:10.1212/01.WNL.0000076183.34915.CD.
20. Roper LS, Saifee TA, Parees I, et al. How to use the entrainment test in the diagnosis of functional tremor. Pract Neurol 2013;13(6): 396-398. doi:10.1136/practneurol-2013-000549.
21. Schrag A, Trimble M, Quinn N, Bhatia K. The syndrome of fixed dystonia: an evaluation of 103 patients. Brain 2004;127(pt 10):2360-2372. doi:10.1093/brain/awh262.
22. Fasano A, Valadas A, Bhatia KP, et al. Psychogenic facial movement disorders: clinical features and associated conditions. Mov Disord 2012;27(12):1544-1551. doi:10.1002/mds.25190.
23. Wolfsegger T, Pischinger B, Topakian R. Objectification of psychogenic postural instability by trunk sway analysis. J Neurol Sci 2013;334(1-2):14-17. doi:10.1016/j.jns.2013.07.006.
24. Avbersek A, Sisodiya S. Does the primary literature provide support for clinical signs used to distinguish psychogenic nonepileptic seizures from epileptic seizures? J Neurol Neurosurg Psychiatry 2010;81(7):719-725. doi:10.1136/jnnp.2009.197996.
25. Chen CS, Lee AW, Karagiannis A, et al. Practical clinical approaches to functional visual loss. J Clin Neurosci 2007;14(1):1-7. doi:10.1016/j.jocn.2006.03.002.
26. Stone J. The bare essentials: functional symptoms in neurology. Pract Neurol 2009; 9(3):179-189. doi:10.1136/jnnp.2009.177204.
27. Stone J, Gelauff J, Carson A. A "twist in the tale": altered perception of ankle position in psychogenic dystonia. Mov Disord 2012;27(4):585-586. doi: 10.1002/mds.24069.
28. Daum C, Gheorghita F, Spatola M, et al. Interobserver agreement and validity of bedside 'positive signs' for functional weakness, sensory and gait disorders in conversion disorder: a pilot study. J Neurol Neurosurg Psychiatry 2014. pii: jnnp-2013-307381. doi:10.1136/jnnp-2013-307381. [Epub ahead of print].
29. Avbersek A, Sisodiya S. Does the primary literature provide support for clinical signs used to distinguish psychogenic nonepileptic seizures from epileptic seizures? J Neurol Neurosurg Psychiatry 2010;81(7):719-725. doi:10.1136/jnnp.2009.197996.
30. Bettini L, Croquelois A, Maeder-Ingvar M, Rossetti AO. Diagnostic yield of short-term video-EEG monitoring for epilepsy and PNESs: a European assessment. Epilepsy Behav 2014;39C: 55-58. doi:10.1016/j.yebeh.2014.08.009.
31. Stone J, Smyth R, Carson A, et al. Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ 2005;331(7523):989.
32. Bell V, Oakley DA, Halligan PW, Deeley Q. Dissociation in hysteria and hypnosis: evidence from cognitive neuroscience. J Neurol Neurosurg Psychiatry 2011;82(3):332-339. doi:10.1136/jnnp.2009.199158.
33. Blakemore RL, Hyland BI, Hammond-Tooke GD, Anson JG. Distinct modulation of event-related potentials during motor preparation in patients withmotor conversion disorder. PLoS One 2013;8(4):e62539. doi:10.1371/journal.pone.0062539.
34. Pareé s I, Brown H, Nuruki A, et al. Loss of sensory attenuation in patients with functional (psychogenic) movement disorders. Brain 2014: 137(pt 11):2916-2921. doi:10.1093/brain/awu237.
35. Edwards MJ, Adams RA, Brown H, et al. A Bayesian account of 'hysteria'. Brain 2012; 135(pt 11):3495-3512. doi:10.1093/brain/aws129.
36. Kanaan R, Armstrong D, Barnes P, Wessely S. In the psychiatrist's chair: how neurologists understand conversion disorder. Brain 2009; 132(pt 10):2889-2896. doi:10.1093/brain/awp060.
37. Pareé s I, Saifee T, Kassavetis P, et al. Believing is perceiving: mismatch between self-report and actigraphy in psychogenic tremor. Brain 2012;135(pt 1):117-123. doi:10.1093/brain/awr292.
38. Stone J, Edwards M. Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology 2012;79(3):282-284. doi:10.1212/WNL.0b013e31825fdf63.
39. Stone J, Reuber M, Carson A. Functional symptoms in neurology: mimics and chameleons. Pract Neurol 2013;13(2):104-113. doi:10.1136/practneurol-2012-000422.
40. Jordbru AA, Smedstad LM, Klungsøyr O, Martinsen EW. Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med 2014;46(2):181-187. doi:10.2340/16501977-1246.
41. Czarnecki K, Thompson JM, Seime R, et al. Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol. Parkinsonism Relat Disord 2012;18(3):247-251. doi:10.1016/j.parkreldis.2011.10.011.
42. Nielsen G, Stone J, Edwards MJ. Physiotherapy for functional (psychogenic) motor symptoms: a systematic review. J Psychosom Res 2013;75(2):93-102. doi:10.1016/j.jpsychores.2013.05.006.
43. Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus recommendation (published online ahead of print November 28, 2014). J Neurol Neurosurg Psychiatry 2014.
44. Nielsen G, Ricciardi L, Demartini B, et al. Outcomes of a 5-day physiotherapy programme for functional (psychogenic) motor disorders (published online ahead of print January 4, 2015). J Neurol 2015.
45. LaFrance WC Jr, Reuber M, Goldstein LH. Management of psychogenic nonepileptic seizures. Epilepsia 2013;54(suppl 1):53-67. doi:10.1111/epi.12106.
46. Goldstein LH, Chalder T, Chigwedere C, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology 2010;74(24):1986-1994. doi:10.1212/WNL.0b013e3181e39658.
47. LaFrance WC Jr, Baird GL, Barry JJ, et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry 2014;71(9):997-1005. doi:10.1001/jamapsychiatry.2014.817.
48. Sharpe M, Walker J, Williams C, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology 2011; 77(6):564-572. doi:10.1212/WNL. 0b013e318228c0c7.
49. Kompoliti K, Wilson B, Stebbins G, et al. Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial. Parkinsonism Relat Disord 2014:20(1):60-63. doi:10.1016/j.parkreldis.2013.09.018.
50. Moene FC, Spinhoven P, Hoogduin CA, van Dyck R. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn 2003;51(1):29-50. doi:10.1076/iceh.51.1.29.14067.
51. Stone J, Hoeritzauer I, Brown K, Carson A. Therapeutic sedation for functional (psychogenic) neurological symptoms. J Psychosom Res 2014;76(2):165-168. doi:10.1016/j.jpsychores.2013.10.003.
52. Chastan N, Parain D. Psychogenic paralysis and recovery after motor cortex transcranial magnetic stimulation. Mov Disord 2010; 25(10):1501-1504. doi:10.1002/mds.23187.
53. Garcin B, Roze E, Mesrati F, et al. Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders. J Neurol Neurosurg Psychiatry 2013;84(9):1043-1046. doi:10.1136/jnnp-2012-304062.
54. O'Malley PG, Jackson JL, Santoro J, et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999;48(12):980-990.
55. Saifee TA, Kassavetis P, Pareés I, et al. Inpatient treatment of functional motor symptoms: a long-term follow-up study. J Neurol 2012;259(9):1958-1963. doi:10.1007/s00415-012-6530-6.
56. McCormack R, Moriarty J, Mellers JD, et al. Specialist inpatient treatment for severe motor conversion disorder: a retrospective comparative study. J Neurol Neurosurg Psychiatry 2014;85(8):895-900. doi:10.1136/jnnp-2013-305716.
57. Demartini B, Batla A, Petrochilos P, et al. Multidisciplinary treatment for functional neurological symptoms: a prospective study. J Neurol 2014;261(12):2370-2377. doi:10.1007/s00415-014-7495-4.